@CNN: When financial incentives like copay coupons and debit cards won’t work, pharmaceutical companies sometimes will write a check — what they call direct reimbursement — to make sure a loyal patient will stay on a high-cost, brand-name drug https://t.co/eypTUmjpRn

When financial incentives like copay coupons and debit cards won't work, pharmaceutical companies sometimes will write a check — what they call direct reimbursement — to make sure a loyal patient will stay on a high-cost, brand-name drug https://t.co/eypTUmjpRn

— CNN (@CNN) December 29, 2018